can i bring my tirzepatide on a plane How to Travel with Wegovy, Zepbound, and Other… Traveling with Tirzepatide: Tips for

A new study, the STEP trial, examined semaglutides impact on cardiovascular outcomes in overweight people or people with obesity and established cardiovascular disease

MGG Molecular & General Genetics

This comparison draws on peer-reviewed clinical data, FDA documentation, and the latest Phase 3 trial results to give you the most complete, evidence-based picture available

Related reading: toxic overload, elevated SAH and impaired methylation

In SUSTAIN-7, a study comparing semaglutide to dulaglutide in patients with inadequately controlled T2DM, a greater reduction in body weight was observed with 0.5 mg semaglutide (4.6 kg, standard error [SE] 0.28) compared with 0.75 mg dulaglutide (2.3 kg, SE 0.27) (estimated treatment difference [ETD] 2.26 kg, 95% CI 3.02 to 1.51